InvestorsHub Logo
Followers 16
Posts 1153
Boards Moderated 0
Alias Born 06/29/2015

Re: None

Thursday, 08/03/2017 2:55:07 PM

Thursday, August 03, 2017 2:55:07 PM

Post# of 158773
Great day today, but my eyes are on the prize. Nice to see us pass .02. However, (and I know this is hard for OTC investors), let's look just a little bit further down the road. The Q2 fins were nothing compared to what is coming. We are entering an exponential growth curve. We can estimate the future revenues and profits based on the Q2 fins, the huge amount of new clinics scheduled to open, eyewitness testimony of # of patients at currently open clinics, and our share structure. .02 is nothing compared to what we'll see with the Q3 fins, annual, and Q1 2018. With the amount of cash coming in, I wouldn't be surprised to also see management improve the share situation, and/or an eventual uplist.

So many OTC investors get caught up in who's buying what and which ticker is the weekly "hot" ticker. These OTC trading methods won't affect us nearly as much, because PAOG is actually making money and will only grow. Legitimate business growth will lead to a legitimate stock price.